Trial No.: Novaris CLEE011O2301C “NATALEE”
Phase II Study of CDK 4/6 Inhibitor, LEE01 (Riboclib), in combination with Adjuvant endocrine therapy at varying Duration for ER-positive Breast Cancer.
Trial No.: NSABP B-59
A randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo.
©2018 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.